Open funding, investment and M&A opportunities


Marble quarry investment.

 

💲  Selling price: 105 M €. Advanced geological studies available. Technical feasibility confirmed (yield: 92% usable material).

📁Sector of activity: acquisition (M&A) opportunity in marble quarry, open-air with novel extraction methods, ready for production, 4-fold ROI expected within 2 years.

Other details: exploitation concession currently active. High-potential mining concession active. Proven reserves of 20M tons of cream ivory marble, (premium grade, market value: 120-250 €/m³ as blocks).

Link to video:  https://dai.ly/k2DC8JizrTRuwjDi0Dk

Contact opportunity team. Ref 0825

Govtech and Medtech and data models.


💲   Funding required: 150k € private funding, 10% anual interest, returned to investors within 6 months.

📁 Sector of activity: this company is maturing a artificial intelligence platform for optimal managing of human migration and mobility.

✅ Other details: the platform is already functional and seeking to broaden services in an increasing number of countries within Europe and EMEA regions.

Contact opportunity team. Ref 0725

Edtech and Medtech. 


💲   Funding required:  Currently seeking a combination of non-dilutive financing and convertible notes.

📁 Sector of activity: Medtech and Edtech.

Other details: Following the close of a €1M pre-seed round, the Founders retain over 80% equity. Team: We have 10+ full-time staff and highly engaged top-tier advisors, some of whom have already invested. Location: Headquartered in Spain. Locations in Navarra, Barcelona and Madrid. Business Model: Highly scalable, accessible product with a large TAM (Total Addressable Market). Applicable globally to healthcare students/professionals (B2C) and clinics, hospitals & universities (B2B). 

Contact opportunity team. Ref 0625

Novel device for Alzheimer, Parkinson and neurodegeneration. 


💲 Funding required: 100k-300k eur Investment Opportunity: Medical Device for Neurodegenerative Diseases. 

📁Sector of activity: Medtech and Edtech. Funding sought to develop a medical device enhancing efficacy & safety of therapies for Alzheimer’s, Parkinson’s & related conditions.

Other details: Now entering human clinical trials. Early-stage investors can participate via a convertible loan note.

Contact opportunity team. Ref 0525

Novel therapies with IA. 


💲 Funding required: 5,5M€ Series A round, in two parts: 2M€ in 2025 and 3,5M€ in 2026. Bridge round of up to 400k € in discounted convertible notes available until end of August 2025. Funds will cover preclinical development and manufacturing expenses required to advance the lead candidate to clinical trials in humans.

📁Sector of activity: Medtech. Novel therapeutic products designed with support of cutting-edge IA tools.  Innovative therapeutic approach with AI-designed compounds. Efficacy data in animal models already available. Return: anticipated 20x+ multiplier at exit for investors in this 2025 round. Exit planned for 2030. 

Other details: solid scientific foundation team, clear development roadmap and long-term vision. Global market, projected to surpass $44B by 2032. 

Contact opportunity team. Ref 0425

Chemical engineering and green hydrogen. 


💲  Funding required:  750,000 €. Funds will cover cash flow for the development, there is a minimum viable product previously developed in collaboration with a Technology Center.

📁Sector of activity: Medtech and Edtech. Investment Opportunity in Chemical Engineering Project: Efficient Hydrolysis and Green Hydrogen Generation. 

✅ Other details: 10% return per annum on invested capital (from investment date), structured as debt with an option to convert into equity upon proven profitability. Guarantee: Established company with a solid track record and diversified operations. Holds a granted subsidy amounting to 2.8M €.

Contact opportunity team. Ref. 0325

Health and Artificial Intelligence. 


💲   Funding required:  150,000 €

📁Sector of activity: Medtech and Edtech. Investment Opportunity in Health-tech & artificial intelligence. Innovative company with strong project portfolio and growth potential.

✅ Other details:  10% return per annum on invested capital (from investment date). Guarantee: Company holds a pending VAT refund (reimbursement expected before end of July).

Contact opportunity team. Ref. 0225

Visual aid for optometrists and low-vision patients. 


💲   Funding required: 650,000 €. 📊

📁 Sector of activity: Medtech and Edtech. Investment Opportunity in Health-tech.  Investment will cover international marketing and expansion.

✅ Other details:  10% return per annum on invested capital (from investment date). Currently looking for novel distributors in any country (already selling in Europe, LATAM, EMEA).

Contact opportunity team. Ref 0125